Rivaroxaban not superior to Aspirin in Prevention of Stroke recurrence Vinay Singh singh15 May 2018 8:25 PM ISTRivaroxaban, an oral factor Xa inhibitor, was found no superior to aspirin in lowering the risk of recurrent stroke after an initial embolic stroke,...
Recent advances in anti-thrombotic therapy for peripheral artery disease Medha Baranwal Baranwal26 May 2018 8:25 PM ISTPeripheral artery disease (PAD) is a circulatory condition characterized by the reduced flow of blood to the limbs due to narrowing of the blood...
DVT and pulmonary embolism secondary to urinary retention: a case report Anjali Nimesh Nimesh4 Jun 2018 7:02 PM ISTIn a unique and rare case of its kind, Tatsushi Kawada and his associates describe a rare instance of a patient who developed deep vein thrombosis and...
Dabigatran, Rivaroxaban, and Apixaban similarly effective in nonvalvular AF Medha Baranwal Baranwal24 July 2018 7:15 PM ISTThe risk for stroke or systemic embolism in patients with nonvalvular atrial fibrillation (AF) is not significantly different between 3 non-vitamin K...
Rivaroxaban as good as LMW Heparin for reducing VTE recurrence in cancer patients Vinay Singh singh27 July 2018 7:10 PM ISTRivaroxaban, a direct oral anti-coagulant (DOAC) was associated with relatively low Venous thromboembolism (VTE) recurrence but higher clinically...
Rivaroxaban has no benefit in cardiac illnesses not associated with AF: NEJM Medha Baranwal Baranwal1 Sept 2018 7:20 PM ISTRivaroxaban, an oral anticoagulant drug does not reduce the risk of death, stroke or myocardial infarction than placebo among patients with worsening...
Lower doses of NOACs don't increase risk of intracranial haemorrhage : JAMA Medha Baranwal Baranwal18 Sept 2018 7:20 PM ISTNOACs are an attractive option for stroke prevention in people without atrial fibrillation but may carry risks of intracranial haemorrhage. A new...
PPIs combined with oral anticoagulants reduce risk of GI bleeding : JAMA Vinay Singh singh6 Dec 2018 7:25 PM ISTPatients at increased risk of gastrointestinal bleeding can be prominently protected from such risk by taking proton pump inhibitor (PPI) in...
NOACs now a preferred alternative to warfarin: Guideline for the Management of Patients With Atrial Fibrillation Medha Baranwal Baranwal29 Jan 2019 7:00 PM ISTThe American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) has released an updated version of its 2014 ...
Andexanet reverses serious bleeding due to Apixaban, Rivaroxaban, confirms study Dr. Kamal Kant Kohli Kohli11 Feb 2019 7:25 PM ISTAccording to late-breaking science presented at the American Stroke Association's International Stroke Conference 2019, Andexanet alfa (Andexxa), the...
First Australasian guidelines for venous thromboembolism released Hina Zahid18 Feb 2019 7:00 PM ISTThe first Australasian guidelines for the diagnosis and management of venous thromboembolism (VTE) and PE have been produced by a working group of...
Adding Rivaroxaban to Aspirin in treatment of Indian Stable CAD patients- Analysis of COMPASS trial in India by Dr Prafulla Kerkar Et al Hina Zahid4 April 2019 7:03 PM ISTThe following article is a critical analysis of the COMPASS trial with respect to benefit-risk assessment using the number needed to treat:...
